Startups · AI

Associate Director, Advanced Analytics & AI Enablement

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

Reporting to the Director, US Commercial Analytics, the Associate Director, Advanced Analytics & AI Enablement will own the specialist predictive and causal methods that improve targeting, promotional investment, and commercial decisions across Revolution Medicines' portfolio. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor's degree in a Science, engineering, or business discipline required, with 6+ years of progressive experience applying advanced analytics in Pharma/Biotech or a comparable commercial environment
  • Demonstrated ownership of predictive modeling and causal methods, including propensity and prediction models, attribution, incrementality, and marketing-mix modeling
  • Deep knowledge of pharmaceutical commercial data assets, including claims, lab, prescription, HCP and account, CRM, and digital engagement data
  • Strong hands-on technical skills in Python or R and SQL, with experience working in cloud analytics environments such as Databricks, Snowflake, or comparable platforms
  • Experience taking models from concept through validation, activation, and monitoring in real business workflows
  • Ability to explain method choice, assumptions, and uncertainty to non-technical commercial leaders and influence decisions accordingly
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

Reporting to the Director, US Commercial Analytics, the Associate Director, Advanced Analytics & AI Enablement will own the specialist predictive and causal methods that improve targeting, promotional investment, and commercial decisions across Revolution Medicines' portfolio. As RevMed prepares for overlapping launches across multiple cancers, many priority HCPs are likely to be relevant to...

Read the full posting on Revolution Medicines's site ↗

US Analytics & Insights

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.